Tanabe Pharma America, Inc.

This study looked at the long-term safety of an oral form of edaravone, a medication for amyotrophic lateral sclerosis (ALS), over 96 weeks. It involved 124 people who had already completed a previous edaravone study. The main goal was to track side effects and see how well patie…

This study tested an experimental drug called MT-3921 in 72 people with recent cervical spinal cord injuries. Participants received either the drug or a placebo over 6 months. The main goal was to see if the drug improves arm and hand movement, measured by a standard motor score.…

This study looked at the long-term safety of an oral version of edaravone, a medicine for ALS (Lou Gehrig's disease). 185 adults with ALS took the pill for up to 48 weeks. The main goal was to see how many side effects occurred. This is not a cure, but a way to help manage the di…

This study tested an experimental drug called MT-7117 in 76 adults with diffuse cutaneous systemic sclerosis, a rare autoimmune disease that causes skin thickening and organ damage. Participants received either the drug or a placebo for 52 weeks. The main goal was to see if MT-71…

This study tested an experimental drug called MT-7117 in 102 adults with erythropoietic protoporphyria (EPP), a rare condition that causes severe pain from sunlight exposure. The goal was to see if the drug could increase the time people could spend in the sun without symptoms. P…

This study looked at the long-term safety of an experimental drug called MT-8554 for reducing moderate to severe hot flashes in postmenopausal women. A total of 190 women who had already completed a 12-week study of the drug took part. The main goal was to check for side effects …

This study tested an experimental drug called MT-8554 to see if it could reduce the number and severity of hot flashes in postmenopausal women. About 375 women who had at least 7 moderate to severe hot flashes per day took either the drug or a placebo. The goal was to measure cha…

This study tested a drug called MT-7117 in 184 people aged 12-75 with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), conditions that cause severe pain from sunlight. The goal was to see if the drug could delay the first signs of sun-related discomfort (burn…

This study tested a drug called MT-2990 in 76 women with surgically diagnosed endometriosis who had moderate to severe pain. The goal was to see if the drug safely reduces pelvic pain and pain during periods or sex over 16 weeks. Participants stopped hormonal treatments before st…

This study looked at how healthy men absorb, break down, and eliminate a single dose of the drug MT-8554. Six participants took the drug and provided blood, urine, and stool samples over time. The goal was to understand the drug's movement in the body, not to treat any disease. N…

This study looked at whether MT-8554, an experimental drug, changes the heart's electrical activity (QT interval) in 48 healthy adults aged 18 to 55. Participants received either a low dose, high dose, or a placebo. The goal was to check for heart rhythm risks, not to treat any d…